Publicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (9)

2019

  1. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process

    BMC Cancer, Vol. 19, Núm. 1

2018

  1. Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma

    Oncotarget, Vol. 9, Núm. 87, pp. 35726-35741

2016

  1. ΔNp63α silences a miRNA program to aberrantly initiate a wound-healing program that promotes TGFβ-induced metastasis

    Cancer Research, Vol. 76, Núm. 11, pp. 3236-3251

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

2013

  1. ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo

    Gene, Vol. 521, Núm. 1, pp. 55-61

  2. FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo

    PLoS ONE, Vol. 8, Núm. 1

  3. Zinc chelation: A metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance

    Cell Death and Disease, Vol. 4, Núm. 10

2011

  1. CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis

    Journal of Bone and Mineral Research, Vol. 26, Núm. 7, pp. 1533-1542